You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cell-in-cell structures

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Soft Tissue Sarcoma, Non Small Cell Lung Cancer, Triple Negative Breast Cancer Trial in France (Ezabenlimab + BI907828)

Not yet recruiting
  • Adult Soft Tissue Sarcoma
  • +4 more
  • Ezabenlimab + BI907828
  • Bordeaux, France
  • +5 more
Oct 19, 2023

Cell-in-cell Structure in Breast Cancer Undergoing Neoadjuvant

Recruiting
  • Breast Neoplasms
  • Neoadjuvant therapy
  • Beijing, Beijing, China
    Beijing Shijitan Hospital, Capital Medical University
Dec 6, 2022

Vessel Wall Enhancement in Giant Cell Arteritis

Recruiting
  • Giant Cell Arteritis
  • Magnetic Resonance Imaging (MRI)
  • Philadelphia, Pennsylvania
    3400 Civic Center Blvd
May 9, 2023

Moesin Expression in Clear Cell Renal Cell Carcinoma

Completed
  • Renal Cell Carcinoma
  • Immunohistochemical detection of Moesin in Clear cell Renal Cell Carcinoma
  • (no location specified)
Sep 20, 2023

Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • +3 more
  • Tazemetostat Pill
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023

Carcinoma, Renal Cell Trial in Pittsburgh (Autologous alpha-DC1/TBVA vaccine, Cabozantinib)

Not yet recruiting
  • Carcinoma, Renal Cell
  • Pittsburgh, Pennsylvania
    UPMC Department of Urology
Jan 5, 2023

Recurrent DLBCL, Refractory Diffuse Large B-cell Lymphoma Trial in Tianjin (RC19D2 cell injection)

Recruiting
  • Recurrent Diffuse Large B-Cell Lymphoma
  • Refractory Diffuse Large B-cell Lymphoma
  • RC19D2 cell injection
  • Tianjin, Tianjin, China
    Hematology Hospital of the Chinese Academy of Medical Sciences
Sep 14, 2023

NK/T-cell Lymphoma Trial in Shanghai (Positron Emission Tomography/Magnetic Resonance (PET/MR))

Not yet recruiting
  • NK/T-cell Lymphoma
  • Positron Emission Tomography/Magnetic Resonance (PET/MR)
  • Shanghai, Shanghai, China
    Ruijin Hospital
Dec 14, 2022

Extranodal NK T Cell Lymphoma, NK-Cell Leukemia Trial in Xuzhou (Anti-CD56 CAR T)

Recruiting
  • Extranodal NK T Cell Lymphoma
  • NK-Cell Leukemia
  • Anti-CD56 CAR T
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Jul 10, 2023

Sickle Cell Disease Trial (SuCCESs)

Not yet recruiting
  • Sickle Cell Disease
  • SuCCESs
  • (no location specified)
Oct 5, 2023

ASCT Versus Chemotherapy as First-Line Consolidation Therapy

Completed
  • T-cell Lymphoma Adults
  • consolidation with ASCT
  • (no location specified)
Nov 25, 2023

Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

Not yet recruiting
  • Clear Cell Renal Cell Carcinoma
  • 68Ga-NY104 PET/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 18, 2023

B-cell Acute Lymphoblastic Leukemia Trial in Hefei (QH103 Cell Injection, Fludarabine, Cyclophosphamide)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • QH103 Cell Injection
  • +2 more
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Sep 21, 2023

Metastatic Clear Cell Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

Not yet recruiting
  • Metastatic Clear Cell Renal Cell Carcinoma
  • 68Ga-NY104 PET/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
May 18, 2023

Primary Mediastinal Large B-cell Lymphoma (PMBCL), Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell

Not yet recruiting
  • Primary Mediastinal Large B-cell Lymphoma (PMBCL)
  • +5 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Nevoid Basal Cell Carcinomas in Gorlin Syndrome

Enrolling by invitation
  • Basal Cell Carcinoma
  • Gorlin Syndrome
  • Active surveillance
  • Oslo, Norway
    Oslo University Hospital
Jun 8, 2023

Clear Cell Renal Cell Carcinoma?Resistance to Immunotherapy Trial in Shanghai (AK104(anti-PD-1/CTLA-4 bi-specific antibody

Recruiting
  • Clear Cell Renal Cell Carcinoma、Resistance to Immunotherapy
  • AK104（anti-PD-1/CTLA-4 bi-specific antibody ，intravenously）,lenvatinib（ targeted VEGFR 1-3、FGFR、PDGFRα， small molecule TKI，orally
  • Shanghai, Shanghai, China
    Shanghai Renji Hospital
Sep 12, 2023

Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy Trial in Durham (SCD-specific COVID-19 vaccination information (SCVI)

Not yet recruiting
  • Sickle Cell Disease
  • +2 more
  • SCD-specific COVID-19 vaccination information (SCVI) video
  • Durham, North Carolina
    Duke Adult Sickle Cell Program
Aug 17, 2023

Large B-cell Lymphoma Trial (Glofitamab, Polatuzumab vedotin, Obinutuzumab)

Not yet recruiting
  • Large B-cell Lymphoma
  • (no location specified)
Oct 3, 2023

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Duarte, Atlanta (procedure, drug,

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Duarte, California
  • +1 more
Sep 22, 2023

Heart Failure, Mechanical Circulatory Support Trial in Ljubljana (CD34+ stem cell therapy)

Recruiting
  • Heart Failure
  • Mechanical Circulatory Support
  • CD34+ stem cell therapy
  • Ljubljana, Slovenia
    University Medical Center Ljubljana
Nov 22, 2023

Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

Not yet recruiting
  • Lymphoma
  • Peripheral Blood Stem Cell Transplantation
  • Eltrombopag olamine
  • (no location specified)
Jul 25, 2023

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Renal Cell Carcinoma Trial in Beijing (68Ga-NY104 PET/CT)

Recruiting
  • Renal Cell Carcinoma
  • 68Ga-NY104 PET/CT
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jun 5, 2023